The Epidemiological Impact of Carbapenemase-Producing and Multidrug-Resistant Bacteria in Northern Morocco: Findings from a Year-Long Observational Study - Report - MDSpire

The Epidemiological Impact of Carbapenemase-Producing and Multidrug-Resistant Bacteria in Northern Morocco: Findings from a Year-Long Observational Study

  • By

  • Kawtar EL Harrak

  • Ikram AL Faqir

  • EL Mehdi EL Ghorba

  • Reda Amrani Souhli

  • Nouhaila Chahid

  • Moussaab Arbai

  • Majda El-Hassouni

  • Fadila Bousgheiri

  • Adil Najdi

  • Karima Rissoul

  • March 14, 2026

  • 0 min

Share

Clinical Report: The Epidemiological Impact of Carbapenemase-Producing Bacteria

Overview

This study investigates the prevalence and resistance profiles of multidrug-resistant (MDR) and carbapenemase-producing bacteria in Northern Morocco. The findings highlight the urgent need for improved infection control measures and surveillance systems in the region.

Background

Multidrug-resistant bacteria pose a significant threat to public health, complicating treatment options and increasing the risk of healthcare-associated infections. In Morocco, the burden of these infections necessitates enhanced strategies for prevention and management. Understanding the epidemiology of these pathogens is crucial for developing effective local interventions.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • The study focused on hospital-acquired multidrug-resistant strains, including MRSA, ESBL-producing Enterobacterales, and CPE.
  • Clinical samples included blood cultures, urine, respiratory samples, and sterile fluids, while screening swabs for colonization were excluded.
  • Antimicrobial susceptibility testing was performed using the BD Phoenix™ M50 system and confirmed by disk diffusion.
  • Carbapenem resistance was screened using multiple carbapenems and confirmed through phenotypic tests and multiplex PCR.
  • Demographic and clinical data were analyzed to assess resistance profiles and associated factors.

Clinical Implications

Healthcare professionals should prioritize infection control measures and surveillance for MDR and DTR organisms in clinical settings. The findings underscore the necessity for multidisciplinary collaboration to address the rising threat of antimicrobial resistance.

Conclusion

The study underscores the critical need for enhanced surveillance and infection control strategies in Northern Morocco to combat the rising prevalence of multidrug-resistant bacteria.

References

  1. Infection — Characterization of Epidemiological and Clinical Aspects of Colonization and Infection by Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli in Community, Healthcare, and Hospital Settings in Spain
  2. Infection — A case-control analysis of the clinical and economic consequences of infections due to Carbapenemase-producing Enterobacterales (CPE)
  3. Open Forum Infectious Diseases — Thirty-Day Mortality Associated With Carbapenemase-Producing Enterobacterales Bloodstream Infections at a Referral Hospital in Peru, 2020–2023
  4. The Journal of Infectious Diseases — An Omics-Guided Investigation of a Hospital Outbreak Caused by blaNDM-1-Producing Pseudocitrobacter faecalis
  5. Global antibiotic resistance surveillance report 2025
  6. MDRO Prevention Strategies | HAIs | CDC
  7. Real-world effectiveness and safety of meropenem-vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysis - PubMed
  8. Global antibiotic resistance surveillance report 2025
  9. MDRO Prevention Strategies | HAIs | CDC
  10. Real-world effectiveness and safety of meropenem-vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysis - PubMed

Original Source(s)

Related Content